Microarrayed Compound Screening (μARCS) to Identify Activators and Inhibitors of AMP-Activated Protein Kinase
Open Access
- 1 March 2004
- journal article
- Published by Elsevier in SLAS Discovery
- Vol. 9 (2) , 112-121
- https://doi.org/10.1177/1087057103260592
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Application of Micro Arrayed Compound Screening (μARCS) to Identify Inhibitors of Caspase-3SLAS Discovery, 2002
- Targeting the AMP-Activated Protein Kinase for the Treatment of Type 2 DiabetesCurrent Drug Target - Immune, Endocrine & Metabolic Disorders, 2002
- Microarray Compound Screening (μARCS) to Identify Inhibitors of HIV IntegraseSLAS Discovery, 2002
- Complex Gel Permeation Assays for Screening Combinatorial LibrariesSLAS Discovery, 2001
- Well-less, gel-permeation formats for ultra-HTSDrug Discovery Today, 2001
- Characterization of the AMP-activated Protein Kinase Kinase from Rat Liver and Identification of Threonine 172 as the Major Site at Which It Phosphorylates AMP-activated Protein KinaseJournal of Biological Chemistry, 1996
- Activation of glycogen phosphorylase and glycogenolysis in rat skeletal muscle by AICAR — an activator of AMP‐activated protein kinaseFEBS Letters, 1996
- 5-Aminoimidazole-4-Carboxamide Ribonucleoside. A Specific Method for Activating AMP-Activated Protein Kinase in Intact Cells?European Journal of Biochemistry, 1995
- Inhibition by AICA Riboside of Gluconeogenesis in Isolated Rat HepatocytesDiabetes, 1991
- Tissue distribution of the AMP‐activated protein kinase, and lack of activation by cyclic‐AMP‐dependent protein kinase, studied using a specific and sensitive peptide assayEuropean Journal of Biochemistry, 1989